e-learning
resources
Madrid 2019
Wednesday, 02.10.2019
Exacerbations of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Transcriptomic footprint of COPD patients with well-defined frequent severe exacerbations.
S. Pascual (Barcelona, Spain), P. Puigdevall (Barcelona, Spain), C. Casadevall (Barcelona, Spain), E. Barreiro (Barcelona, Spain), R. Castelo (Barcelona, Spain), J. Gea Guiral (Barcelona, Spain)
Source:
International Congress 2019 – Exacerbations of airway diseases
Session:
Exacerbations of airway diseases
Session type:
Poster Discussion
Number:
5233
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Pascual (Barcelona, Spain), P. Puigdevall (Barcelona, Spain), C. Casadevall (Barcelona, Spain), E. Barreiro (Barcelona, Spain), R. Castelo (Barcelona, Spain), J. Gea Guiral (Barcelona, Spain). Transcriptomic footprint of COPD patients with well-defined frequent severe exacerbations.. 5233
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Asbestosis
Whole genome sequencing of the highly virulent subtype B0/W148 of the Beijing genotype M.tuberculosis in Kharkiv, East Ukraine
Related content which might interest you:
Analysis of the causes for the frequent exacerbations and hospitalisations in patients with COPD
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
Predicting frequent exacerbations in a severe asthma centre.
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020
Impact of moderate and severe exacerbations in severe COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Markers of T2-inflammation in patients with severe asthma and concomitant COPD
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Are comorbidities related to frequent severe exacerbations of COPD?
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Characterization of patients with severe COPD
Source: International Congress 2018 – COPD around the world
Year: 2018
Genetic comparison between severe persistent asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 81s
Year: 2003
Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations
Source: Eur Respir J 2007; 30: Suppl. 51, 72s
Year: 2007
Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma
Source: Eur Respir J, 50 (3) 1602298; 10.1183/13993003.02298-2016
Year: 2017
Predictors of severe exacerbations in patients with moderate and severe asthma
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. A comparative syudy
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Long-term effect of roflumilast on exacerbations in patients with severe to very severe COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 526s
Year: 2006
Factors associated with frequent exacerbations in patients with severe asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 369s
Year: 2001
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD
Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020
Year: 2021
Midrange-proadrenomedullin in stable state predicts severe exacerbation of COPD
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013
Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept